A scientific breakthrough.. Proving the effectiveness of a drug in reducing Alzheimer’s

British scientists achieved a new scientific breakthrough that may end the suffering of tens of millions around the world, when they proved the effectiveness of a drug called “donanimab” in the treatment of Alzheimer’s disease.

The scientists said: During their trials of the new drug, half of the patients’ symptoms did not worsen for at least a year, and they were better able to hold conversations, manage their money, or enjoy hobbies than people who were not given the drug, which works by breaking down the harmful “amyloid” plaques that accumulate. in the brain.

And a British newspaper quoted Dr. Richard Oakley, Director of Research at the Alzheimer’s Society in the United Kingdom, as saying: After 20 years of no new drugs for Alzheimer’s disease, we now have two potential new drugs within just twelve months, indicating that this may be the beginning. The end of Alzheimer’s disease.

For his part, Dr. Mark Bosch, a researcher at the UK’s Dementia Research Institute, explained that this clinical trial represents real progress, as it shows a significant slowdown in cognitive decline.

He believed that this treatment has the potential to dramatically improve the lives of patients and their families today, and will end the suffering of tens of millions.